Early Detection Targeted Grants were added to the Pancreatic Cancer Action Network’s grants portfolio in 2017. The grants are designed to focus on identifying novel biomarkers or improving imaging strategies to diagnose the disease in its earlier, more treatable stages.
In 2017, five Early Detection Targeted Grants were awarded. Click below to learn about these grantees and their funded projects.
2017 Pancreatic Cancer Action Network Early Detection Targeted Grant
Anirban Maitra, MBBS
Co-PI: Samir Hanash, MD, PhD
MD Anderson Cancer Center
Optimizing Biomarker Combinations for Pancreatic Cancer Early Detection
2017 Pancreatic Cancer Action Network Early Detection Targeted Grant
Gloria Petersen, PhD
Mayo Clinic
Validation and Temporal Performance of Pancreatic Cancer Biomarkers in Prospective Cohorts
2017 Pancreatic Cancer Action Network Early Detection Targeted Grant
Brett Sheppard, MD
Co-PI: Rosalie Sears, PhD
Oregon Health & Science University
Blood-based and Imaging Biomarkers of PDAC in New-onset Diabetics
2017 Pancreatic Cancer Action Network Early Detection Targeted Grant
Yu-Xiao Yang, MD, MSCE, FACP
University of Pennsylvania
Validation of a Model Predicting Pancreatic Cancer in New-onset Diabetes
2017 Pancreatic Cancer Action Network Early Detection Targeted Grant
Kenneth Zaret, PhD
University of Pennsylvania
Early Detection of PDAC in New-onset Diabetes and Other Cohorts